Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Buckner

Showing results (241-250 of 417) with videos related to

Pageof 42
Sort By:
Experimental Hematology|March 1, 1987
Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgensK Doney, R Storb, C D Buckner, et al.
Bone Marrow Transplantation|October 1, 1994
Phase I study of recombinant human interleukin-1 beta (rhIL-1 beta) in patients with bone marrow failureJ Nemunaitis, M Ross, B Meisenberg, et al.
Cancer Chemotherapy Reports|September 1, 1974
High-dose cyclophosphamide (NSC-26271) for the treatment of metastatic testicular neoplasmsC D Buckner, R A Clift, A Fefer, et al.
Transplantation Proceedings|February 1, 1987
Marrow transplantation for leukemia and aplastic anemia: two controlled trials of a combination of methotrexate and cyclosporine v cyclosporine alone or methotrexate alone for prophylaxis of acute graft-v-host diseaseR Storb, H J Deeg, J Whitehead, et al.
Blood|October 1, 1993
Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factorC H Weaver, C D Buckner, K Longin, et al.
Bone Marrow Transplantation|April 1, 1996
Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levelsT Demirer, C D Buckner, F R Appelbaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1987
Marrow transplantation for acute nonlymphocytic leukemia following therapy for Hodgkin's diseaseM Sargur, C D Buckner, F R Appelbaum, et al.
Blood|August 15, 1991
Graft-versus-host disease prophylaxis with methotrexate/cyclosporine in children with severe aplastic anemia treated with cyclophosphamide and HLA-identical marrow graftsR Storb, J E Sanders, M Pepe, et al.
American Journal of Hematology|January 1, 1978
Relapse following marrow transplantation for acute leukemiaD T Harrison, N Flournoy, R Ramberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapyJ Mortimer, M A Blinder, S Schulman, et al.
Pageof 42

Showing results (241-250 of 417) with videos related to

Sort By:
Pageof 42
Experimental Hematology|March 1, 1987
Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgensK Doney, R Storb, C D Buckner, et al.
Bone Marrow Transplantation|October 1, 1994
Phase I study of recombinant human interleukin-1 beta (rhIL-1 beta) in patients with bone marrow failureJ Nemunaitis, M Ross, B Meisenberg, et al.
Cancer Chemotherapy Reports|September 1, 1974
High-dose cyclophosphamide (NSC-26271) for the treatment of metastatic testicular neoplasmsC D Buckner, R A Clift, A Fefer, et al.
Transplantation Proceedings|February 1, 1987
Marrow transplantation for leukemia and aplastic anemia: two controlled trials of a combination of methotrexate and cyclosporine v cyclosporine alone or methotrexate alone for prophylaxis of acute graft-v-host diseaseR Storb, H J Deeg, J Whitehead, et al.
Blood|October 1, 1993
Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factorC H Weaver, C D Buckner, K Longin, et al.
Bone Marrow Transplantation|April 1, 1996
Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levelsT Demirer, C D Buckner, F R Appelbaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1987
Marrow transplantation for acute nonlymphocytic leukemia following therapy for Hodgkin's diseaseM Sargur, C D Buckner, F R Appelbaum, et al.
Blood|August 15, 1991
Graft-versus-host disease prophylaxis with methotrexate/cyclosporine in children with severe aplastic anemia treated with cyclophosphamide and HLA-identical marrow graftsR Storb, J E Sanders, M Pepe, et al.
American Journal of Hematology|January 1, 1978
Relapse following marrow transplantation for acute leukemiaD T Harrison, N Flournoy, R Ramberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapyJ Mortimer, M A Blinder, S Schulman, et al.
Pageof 42